Kari Chansky

29.6k total citations · 3 hit papers
83 papers, 9.0k citations indexed

About

Kari Chansky is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Kari Chansky has authored 83 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Pulmonary and Respiratory Medicine, 57 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Kari Chansky's work include Lung Cancer Treatments and Mutations (50 papers), Lung Cancer Research Studies (37 papers) and Lung Cancer Diagnosis and Treatment (32 papers). Kari Chansky is often cited by papers focused on Lung Cancer Treatments and Mutations (50 papers), Lung Cancer Research Studies (37 papers) and Lung Cancer Diagnosis and Treatment (32 papers). Kari Chansky collaborates with scholars based in United States, United Kingdom and Canada. Kari Chansky's co-authors include Peter Goldstraw, John Crowley, Ramón Rami–Porta, Pieter E. Postmus, Valerie W. Rusch, Dorothy J. Giroux, Patti A. Groome, Leslie H. Sobin, David R. Gandara and John J. Crowley and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Kari Chansky

83 papers receiving 8.8k citations

Hit Papers

The IASLC Lung Cancer Staging Project: Proposals for the ... 2007 2026 2013 2019 2007 2015 2009 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours
    2007 2.9k citations Peter Goldstraw, John Crowley et al. Journal of Thoracic Oncology profile →
  2. The International Association for the Study of Lung Cancer Lung Cancer Staging Project
    2015 455 citations Hisao Asamura, Kari Chansky et al. Journal of Thoracic Oncology profile →
  3. The International Association for the Study of Lung Cancer Staging Project: Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer
    2009 370 citations Kari Chansky, John J. Crowley et al. Journal of Thoracic Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kari Chansky United States 37 6.7k 4.9k 1.4k 1.2k 1.1k 83 9.0k
Masaaki Kawahara Japan 34 4.2k 0.6× 4.3k 0.9× 1.5k 1.0× 565 0.5× 1.6k 1.4× 115 6.6k
Mark R. Green United States 37 7.3k 1.1× 5.0k 1.0× 979 0.7× 1.0k 0.9× 1.1k 0.9× 131 9.8k
Wilfried Eberhardt Germany 39 5.3k 0.8× 4.2k 0.9× 1.7k 1.2× 895 0.8× 429 0.4× 239 7.6k
Élisabeth Quoix France 43 5.4k 0.8× 5.1k 1.0× 2.0k 1.4× 468 0.4× 1.3k 1.1× 256 8.3k
Kiyoyuki Furuse Japan 36 4.3k 0.6× 3.8k 0.8× 1.0k 0.7× 655 0.6× 784 0.7× 155 6.4k
William T. Sause United States 50 8.3k 1.2× 4.7k 1.0× 1.0k 0.7× 1.8k 1.5× 2.0k 1.8× 173 12.3k
Andrew T. Turrisi United States 47 7.8k 1.2× 5.0k 1.0× 1.3k 0.9× 1.8k 1.6× 2.2k 1.9× 133 11.1k
Masahiro Tsuboi Japan 56 10.6k 1.6× 5.3k 1.1× 1.5k 1.1× 2.5k 2.2× 638 0.6× 377 13.7k
Dorothy J. Giroux United States 23 5.8k 0.9× 2.2k 0.5× 668 0.5× 1.4k 1.2× 614 0.5× 39 7.3k
Ramón Rami–Porta Spain 33 9.0k 1.3× 3.0k 0.6× 738 0.5× 2.4k 2.1× 469 0.4× 127 10.3k

Countries citing papers authored by Kari Chansky

Since Specialization
Citations

This map shows the geographic impact of Kari Chansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Chansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Chansky more than expected).

Fields of papers citing papers by Kari Chansky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari Chansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Chansky. The network helps show where Kari Chansky may publish in the future.

Co-authorship network of co-authors of Kari Chansky

This figure shows the co-authorship network connecting the top 25 collaborators of Kari Chansky. A scholar is included among the top collaborators of Kari Chansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari Chansky. Kari Chansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chansky, Kari, et al.. (2024). Real‐world analysis of the relationships between smoking, lung cancer stigma, and emotional functioning. Cancer Medicine. 13(3). e6702–e6702. 5 indexed citations
2.
Kelly, Karen, Kari Chansky, Philip C. Mack, et al.. (2013). Chemotherapy Outcomes by Histologic Subtypes of Non–Small-Cell Lung Cancer: Analysis of the Southwest Oncology Group Database for Antimicrotubule-Platinum Therapy. Clinical Lung Cancer. 14(6). 627–635. 11 indexed citations
3.
Pisters, Katherine M.W., Eric Vallières, John J. Crowley, et al.. (2010). Surgery With or Without Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S9900, an Intergroup, Randomized, Phase III Trial. Journal of Clinical Oncology. 28(11). 1843–1849. 167 indexed citations
4.
Mack, Philip C., Mary W. Redman, Kari Chansky, et al.. (2010). KRAS and EGFR mutations in the molecular epidemiology of NSCLC: Interim analysis of S0424.. Journal of Clinical Oncology. 28(15_suppl). 7013–7013. 6 indexed citations
5.
Davies, Angela M., Kari Chansky, Primo N. Lara, et al.. (2009). Bortezomib Plus Gemcitabine/Carboplatin as First-Line Treatment of Advanced Non-small Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S0339). Journal of Thoracic Oncology. 4(1). 87–92. 64 indexed citations
6.
Kelly, Karen, Kari Chansky, Laurie E. Gaspar, et al.. (2008). Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023. Journal of Clinical Oncology. 26(15). 2450–2456. 421 indexed citations
7.
Natale, Ronald B., Primo N. Lara, Kari Chansky, et al.. (2008). S0124: A randomized phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated extensive stage small cell lung cancer (E-SCLC). Journal of Clinical Oncology. 26(15_suppl). 7512–7512. 27 indexed citations
8.
Travis, William D., Dorothy J. Giroux, Kari Chansky, et al.. (2008). The IASLC Lung Cancer Staging Project: Proposals for the Inclusion of Broncho-Pulmonary Carcinoid Tumors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer. Journal of Thoracic Oncology. 3(11). 1213–1223. 187 indexed citations
9.
Sculier, Jean‐Paul, Kari Chansky, John J. Crowley, Jan P. van Meerbeeck, & Peter Goldstraw. (2008). The Impact of Additional Prognostic Factors on Survival and their Relationship with the Anatomical Extent of Disease Expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the Proposals for the 7th Edition. Journal of Thoracic Oncology. 3(5). 457–466. 268 indexed citations
10.
Goldstraw, Peter, John Crowley, Kari Chansky, et al.. (2007). The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours. Journal of Thoracic Oncology. 2(8). 706–714. 2911 indexed citations breakdown →
11.
Pisters, Katherine M.W., Eric Vallières, Paul A. Bunn, et al.. (2007). S9900: Surgery alone or surgery plus induction (ind) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Follow-up on a phase III trial. Journal of Clinical Oncology. 25(18_suppl). 7520–7520. 29 indexed citations
12.
13.
West, Howard, Wilbur A. Franklin, Jason McCoy, et al.. (2006). Gefitinib Therapy in Advanced Bronchioloalveolar Carcinoma: Southwest Oncology Group Study S0126. Journal of Clinical Oncology. 24(12). 1807–1813. 114 indexed citations
14.
Lara, Primo N., Kari Chansky, Angela M. Davies, et al.. (2006). Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327). Journal of Thoracic Oncology. 1(9). 996–1001. 29 indexed citations
15.
Davies, Angela M., Kari Chansky, Derick Lau, et al.. (2006). Phase II Study of Consolidation Paclitaxel After Concurrent Chemoradiation in Poor-Risk Stage III Non–Small-Cell Lung Cancer: SWOG S9712. Journal of Clinical Oncology. 24(33). 5242–5246. 30 indexed citations
16.
Chansky, Kari, Jacqueline Benedetti, & John S. Macdonald. (2005). Differences in toxicity between men and women treated with 5‐fluorouracil therapy for colorectal carcinoma. Cancer. 103(6). 1165–1171. 114 indexed citations
17.
18.
19.
West, Howard, Wilbur A. Franklin, Paul H. Gumerlock, et al.. (2003). O-187 ZD1839 (iressa) in advanced bronchioloalveolar carcinoma (BAC): A preliminary report of SWOG SO126. Lung Cancer. 41. S56–S56. 14 indexed citations
20.
Amory, John K., Howard A. Chansky, Kari Chansky, et al.. (2002). Preoperative Supraphysiological Testosterone in Older Men Undergoing Knee Replacement Surgery. Journal of the American Geriatrics Society. 50(10). 1698–1701. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaaki Kawahara Breakdown of academic impact, for papers by Mark R. Green Breakdown of academic impact, for papers by Wilfried Eberhardt Breakdown of academic impact, for papers by Élisabeth Quoix Breakdown of academic impact, for papers by Kiyoyuki Furuse Breakdown of academic impact, for papers by William T. Sause Breakdown of academic impact, for papers by Andrew T. Turrisi Breakdown of academic impact, for papers by Masahiro Tsuboi Breakdown of academic impact, for papers by Dorothy J. Giroux Breakdown of academic impact, for papers by Ramón Rami–Porta
Rankless by CCL
2026